Big Pharma in Damage Control, By Brian Simpson
It did not take long; Trump winning the presidency meant that Robert Kennedy Jr would be able to run on the health and vaccine issue. As we know, Kennedy is one of the leading vax critics, and certainly of the Covid vax, so he will be investigating everything, and the Covid vax issue is the right place to start, to take one down the vaccine rabbit hole. This is well-known to Big Pharma, and there is a concern, following Covid, of a decline in confidence of the general population in vaccines: https://www.pharmaceutical-technology.com/news/gsk-ceo-addresses-declining-trust-in-vaccines-following-trump-re-election/.
Who can blame people?
Big Pharma has been looking at ways of countering this, and the arrival of Robert Kennedy Jr adds to this problem for them. Oh, to be a fly on the wall:
"Following President-elect Donald Trump's victory, executives from the top five pharmaceutical companies reportedly held an emergency meeting to discuss potential regulatory shake-ups. Concerns have intensified with Robert F. Kennedy Jr., an outspoken critic of federal health agencies, set to play a significant role in restructuring public health regulations under the new administration.
Jamel Holley, a New Jersey assemblyman and advisor to Kennedy, stated, "The top CEOs are in a state of panic," adding that the teleconference addressed a new "threat environment" as the pharmaceutical sector braces for major policy shifts.
Kennedy, who has criticized the FDA's regulatory processes, announced that he intends to dismantle the FDA's nutrition department, accusing it of failing to protect American health, particularly that of children. "The FDA's nutrition department has to go. They're not doing their job," Kennedy stated in an interview with MSNBC, citing discrepancies in food safety standards between the U.S. and other countries. "Why do we have Froot Loops with nearly 20 ingredients here when it's only a few in Canada?" he questioned.
https://twitter.com/jamelholley/status/1854253609241735504?
Pharmaceutical stocks dipped in early trading on Wednesday amid concerns about the potential policy changes and uncertainty around forthcoming health regulations. Analysts suggest that Kennedy's potential restructuring of federal health agencies could lead to substantial shifts in market dynamics for the pharmaceutical industry.
Kennedy has also pledged to target what he describes as systemic "corruption" within federal agencies. "I can get the corruption out of the agencies," he remarked, emphasizing his history of litigating against major agencies. "Once Americans are getting good science and allowed to make their own choices, they're going to get a lot healthier."
The great shake up of US health is beginning, and the hope is that there will be a kick-one effect for other jurisdictions, such as Australia.
Comments